Twilight Venture Partners invests exclusively in early-stage biotech and med tech companies.
Twilight Venture Partners invests exclusively in early-stage biotech and med tech companies. Their Partners each have CEO-level experience, which they leverage to select outstanding companies and provide guidance to their management teams. Throughout their careers they have earned the trust and respect of clinicians, patients, regulators, and investors by bringing to market products that improve clinical outcomes and operating with uncompromised honesty.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jul 27, 2020
MBX Biosciences
|
Series A | $34.60M | Biotechnology | — |